1. FY27 revenue - Rs. 3,000 crores Pending - At the Q3 FY26 call, the CFO guided that estimated projected revenue for FY27 would be around Rs. 3,000 crores. FY26 annual revenue was Rs. 1,002 crores and the confirmed order book for FY27 stood at close to Rs. 1,100 crores plus, with the FY27 horizon not yet reached.
2. Data centre capacity deployment - 40 MW by FY28, 80 MW by FY29, 100 MW by FY32 Pending - At the Q3 FY26 call, management guided a staggered data centre deployment of 40 MW by FY28, 80 MW by FY29, and 100 MW by FY32, later pulling first-line readiness forward to Q1 2027 with revenue from H1 2027. No MW has been commissioned or made operational to date.
3. Consolidated revenue growth from FY27 - 25% to 30% YoY Pending - At the Q3 FY26 call, management guided consolidated revenue growth of 25% to 30% year-on-year from FY27 onwards, refined at the Q4 FY26 call to around 30% beyond FY27. FY26 revenue growth was 25.73%, with the FY27 horizon not yet reached.
4. Global Impex acquisition - valuation ongoing, details shortly On track - At the Q3 FY26 call, management stated the valuation process was ongoing and details would be announced shortly, and by the Q4 FY26 call in-principle BSE approval had been received. A proposal to issue 17,00,00,000 shares for 100% control of GIX valued at Rs. 372.81 crores was subsequently announced, with management indicating the next step was to conduct a meeting and follow due process to complete the acquisition.
5. Sustainable EBITDA margin - 10% to 15% On track - At the Q4 FY26 call, management stated the sustainable EBITDA margin range going forward would be 10% to 15%. FY26 OPM was 12.52%, falling within the guided 10-15% range.
6. FY27 CAPEX - at least Rs. 150-200 crores minimum Pending - At the Q4 FY26 call, management guided that CAPEX for the year would be at least Rs. 150 crores to Rs. 200 crores as a minimum budget. No FY27 CAPEX actuals are available, with the FY27 horizon not yet reached.
7. Gross margin improvement - at least 5% to 6% rise from current level Pending - At the Q4 FY26 call, management stated that gross margin should see at least a 5% to 6% rise from the current level moving forward. No disclosed gross margin figures or subsequent improvement read is available.
8. Revenue mix target - 80:20 private enterprise to government On track - At the Q4 FY26 call, management stated the revenue mix target going forward would be approximately 80:20 private enterprise to government. The Q4 FY26 call reported customer concentration already at approximately an 80:20 ratio of private sector to government.
9. FY27 revenue mix by segment - 40-45% AI/cybersecurity, enterprise apps second, healthcare improving, IT consulting rest Pending - At the Q4 FY26 call, management guided the FY27 revenue mix as 40-45% from AI-First cybersecurity, enterprise applications second, healthcare improving, and IT consulting as the rest. Q4 FY26 actual mix was cybersecurity 46-47%, enterprise applications 24-26%, and healthcare around 14% plus, with the FY27 horizon not yet reached.
10. BluBio investment in Andhra Pradesh - \~Rs. 400 crores Pending - The company committed to invest approximately ₹400 crores in Andhra Pradesh's healthcare sector under a 12-month MoU with APEDB signed on 20th November 2025. No disclosed investment deployment under the BluBio MoU has been recorded.
11. KRCL + BSNL combined business - minimum revenue INR 178 crore over two years (Phase 1) Pending - The combined business approach with KRCL and BSNL was anticipated to generate a minimum revenue of INR 178 crore over a two-year Phase 1 period from 17th December 2025. No disclosed revenue actuals from the KRCL+BSNL combined business have been recorded.
12. Edge AI Chip project with Byte Eclipse - Phase 1 $15 million, completed within 18 months Pending - Phase 1 of the Edge AI Chip project with Byte Eclipse, valued at $15 million, was expected to be completed within 18 months from 29th October 2025. A formal Joint Venture was formed for the EclipseX1 Edge-AI Chip with a business potential of US $65-80 million over five years, but no completion read on Phase 1 is available.
13. Fundraise - up to Rs. 345.15 crores via warrants for growth, investments, capex, working capital Pending - The company proposed to raise up to Rs. 345,15,00,000 by issuance of up to 2,95,00,000 warrants convertible at Rs. 117 each on a preferential basis, with ICRA Limited appointed as monitoring agency. No disclosure of funds received or utilisation from this warrant issue has been recorded.